Yu-Jun Shi
Overview
Explore the profile of Yu-Jun Shi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Che F, Xu Q, Li Q, Huang Z, Yang C, Wang L, et al.
World J Gastroenterol
. 2022 May;
28(14):1479-1493.
PMID: 35582676
Background: The phosphorylation status of β-arrestin1 influences its function as a signal strongly related to sorafenib resistance. This retrospective study aimed to develop and validate radiomics-based models for predicting β-arrestin1...
12.
Liao R, Shi Y, Chuong M, Cao J
Front Oncol
. 2022 Apr;
12:873240.
PMID: 35480121
No abstract available.
13.
Li B, Chen P, Tan Y, Huang H, Jiang M, Wu Z, et al.
World J Gastroenterol
. 2021 Nov;
27(39):6701-6714.
PMID: 34754162
Background: Standard liver weight (SLW) is frequently used in deceased donor liver transplantation to avoid size mismatches with the recipient. However, some deceased donors (DDs) have fatty liver (FL). A...
14.
Yang J, Huang J, Chen X, Ling W, Luo Y, Shi Y, et al.
Eur Radiol
. 2021 Oct;
32(3):2131-2132.
PMID: 34648042
No abstract available.
15.
Yang J, Huang J, Chen X, Ling W, Luo Y, Shi Y, et al.
Eur Radiol
. 2021 Jan;
31(8):6397-6405.
PMID: 33492470
Objectives: To evaluate the relationship between contrast-enhanced (CE) ultrasound Liver Reporting and Data System (LI-RADS) classification of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) and their histopathological component predominance, and to determine if the...
16.
Ma W, Jin Y, Wu Z, Yang Q, Wang J, Liu F, et al.
HPB (Oxford)
. 2020 May;
22(7):939-949.
PMID: 32349925
Background: This meta-analysis was performed by analyzing randomized controlled trials (RCTs) to assess the potential prognostic value of adjuvant chemotherapy (ACT) for patients with resected biliary tract cancers (BTCs). Methods:...
17.
Huang J, Li J, Lu Q, Luo Y, Lin L, Shi Y, et al.
Radiology
. 2019 Dec;
294(2):329-339.
PMID: 31793849
Background American College of Radiology contrast agent-enhanced US Liver Imaging Reporting and Data System (CEUS LI-RADS) was developed to improve the accuracy of hepatocellular carcinoma (HCC) diagnosis at contrast agent-enhanced...
18.
Ma W, Wu Z, Yang Q, Hu H, Wang J, Shi Y, et al.
Clin Res Hepatol Gastroenterol
. 2019 Aug;
44(3):356-367.
PMID: 31420296
Background: The gram-negative bacteria secreted endotoxin, Lipopolysaccharide (LPS), plays important roles in the formation and recurrence of hepatolithiasis and chronic biliary inflammation in patients of Southeast Asia. We aimed to...
19.
Zhu Y, Xu Q, Shao M, Cao X, Wu Z, Chen Y, et al.
Hepatobiliary Pancreat Dis Int
. 2019 Aug;
18(5):464-470.
PMID: 31402267
Background: Intrahepatic cholangiocarcinoma (ICC) is a highly malignant primary tumor in the liver, and the rates of incidence and mortality are rapidly increasing globally. Histone deacetylase 8 (HDAC8) is a...
20.
Ma W, Wu Z, Hu H, Wang J, Yin C, Shi Y, et al.
J Gastrointest Surg
. 2019 Jun;
24(7):1619-1629.
PMID: 31147975
Aim: The aim of this study is to compare the effects of extended lymphadenectomy (E-LD) and regional lymphadenectomy (R-LD) on outcome after radical resection of hilar cholangiocarcinoma (HCCA). Methods: Data...